Latest news

« Back to news

Severn Pathology event explored genomics in the NHS

30 September 2014

In September, Severn Pathology hosted an event at Southmead Hospital Bristol which looked at the future of genomics in the NHS. Over the summer the Government announced a project to sequence 100,000 genes by 2017 - particularly mapping rare diseases and cancers. This project will really help scientists and health professionals begin to understand how diseases develop, to make predictions on disease and potentially to prevent it occurring.

The event hosted by Severn Pathology at North Bristol NHS Trust (NBT) saw academics from the local universities come together with NBT pathologists to discuss how they can collaborate on projects which bring real benefits to patients.

UWE Pro Vice-Chancellor for Research and Business Engagement Professor Martin Boddy talked about their 2020 strategy and their plans for progressing the Science Park at Coldharbour Lane. This is another fantastic example of the academic and health community in Bristol coming together to look at how it can transform healthcare from the perspective of reducing and preventing disease rather than just treating it.

Genomics will play a growing role over the next few years in transforming care and Bristol is fortunate to have a very talented team and well regarded service in Bristol Genetics Laboratory. Similar events are being planned to engage with GPs too. If you're interested in finding our more about advances in pathology contact David Gibbs, Service Manager: david.gibbs@nbt.nhs.uk or Eileen Roberts Head of Genetics: Eileen.roberts@nbt.nhs.uk

Severn Pathology event explored genomics in the NHS
Tags
powered by Hummingbird CMS